Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study

BACKGROUND: Typhoid causes significant mortality among young children in resource-limited settings. Conjugate typhoid vaccines could significantly reduce typhoid-related child deaths, but only one WHO-prequalified typhoid conjugate vaccine exists for young children. To address this gap, we investiga...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:EClinicalMedicine
Autori principali: Capeding, Maria Rosario, Sil, Arijit, Tadesse, Birkneh Tilahun, Saluja, Tarun, Teshome, Samuel, Alberto, Edison, Kim, Deok Ryun, Park, Eun Lyeong, Park, Ju Yeon, Yang, Jae Seung, Chinaworapong, Suchada, Park, Jiwook, Jo, Sue-Kyoung, Chon, Yun, Yang, Seon-Young, Ryu, Ji Hwa, Cheong, Inho, Shim, Kyu-Young, Lee, Yoonyeong, Kim, Hun, Lynch, Julia A., Kim, Jerome H., Excler, Jean-Louis, Wartel, T. Anh, Sahastrabuddhe, Sushant
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2020
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7599314/
https://ncbi.nlm.nih.gov/pubmed/33150320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2020.100540
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi